Estrella Immunopharma names Cynthia Pussinen CEO and board chair

ESLA•2026-10-29

Estrella Immunopharma appointed Cynthia Pussinen CEO, a Class I director and board chair, effective October 25, 2026. Cheng Liu moved from CEO to chief scientific officer on the same date.

1. Leadership changes

Estrella Immunopharma appointed Cynthia Pussinen CEO, a Class I director and board chair, effective October 25, 2026. Pussinen served as managing director, biotech investments, at Sorbie Bornholm from March to October 2026 and previously led Sernova as CEO. Cheng Liu moved from CEO to chief scientific officer, effective October 25.

Sources

Estrella Immunopharma names Cynthia Pussinen CEO and board chair

Sec

Estrella Immunopharma names Cynthia Pussinen CEO and board chair

1. Leadership changes

Related News

Leader’s Advantage raises IPO gross proceeds to $156.5 million after over-allotment exercise

Super Micro Computer grants 14,000 restricted stock units to Chief Business Officer Vikranth Malyala

Sensient Technologies declares quarterly dividend of $0.41 per share

Sources

Estrella Immunopharma names Cynthia Pussinen CEO and board chair

Starbucks sees annual profit above estimates as turnaround gains traction

ProKidney signs agreement with Jefferies for up to $200 million at-the-market share offering